Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

WuXi Biologics (Cayman) Inc. WXIBF

Set alert

Price alert · WXIBF

All alert types
5.69 USD -0.22 -3.64%

At close · Oct 30

6.45 Day range 6.45
3.90 52-week range 7.49
YTD
+34.72%
1 year
+26.33%
Open
6.45
Prev close
5.90
Mkt cap
23.40B
Vol
4.00K
Avg vol
4.73K
EPS
0.17
P/E
33.44
More statistics
Low
6.45
High
6.45
Earnings
Aug 25, 2026

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for WXIBF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

9.68 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B+3 / 5 overall

  • DCF 1
  • Return on Equity 4
  • Return on Assets 4
  • Debt / Equity 4
  • P/E 2
  • P/B 3

Valuation

P/E 24.8×
FY 2016: 42.8×FY 2017: 20.8×FY 2018: 30.7×FY 2019: 36.9×FY 2020: 191×FY 2021: 95.2×FY 2022: 46.5×FY 2023: 32.5×FY 2024: 19.3×FY 2025: 24.8×
FY 2016 5y median 32.5× FY 2025
P/S 5.6×
FY 2016: 6.1×FY 2017: 3.3×FY 2018: 7.6×FY 2019: 10.0×FY 2020: 61.5×FY 2021: 33.0×FY 2022: 13.5×FY 2023: 6.4×FY 2024: 3.5×FY 2025: 5.6×
FY 2016 5y median 6.4× FY 2025
P/B 2.5×
FY 2016: 22.3×FY 2017: 1.3×FY 2018: 2.4×FY 2019: 3.1×FY 2020: 16.8×FY 2021: 10.5×FY 2022: 5.9×FY 2023: 2.7×FY 2024: 1.5×FY 2025: 2.5×
FY 2016 5y median 2.7× FY 2025
P/FCF 42.5×
FY 2016: -17.4×FY 2017: -16.4×FY 2018: -18.1×FY 2019: -19.6×FY 2020: -83.3×FY 2021: -110×FY 2022: -630×FY 2023: 251×FY 2024: 50.2×FY 2025: 42.5×
FY 2016 5y median 42.5× FY 2025
EV/EBITDA 13.7×
FY 2016: 21.9×FY 2017: 10.3×FY 2018: 17.3×FY 2019: 26.2×FY 2020: 148×FY 2021: 74.1×FY 2022: 32.8×FY 2023: 19.0×FY 2024: 9.5×FY 2025: 13.7×
FY 2016 5y median 19.0× FY 2025
EV/Sales 5.3×
FY 2016: 7.1×FY 2017: 3.0×FY 2018: 6.0×FY 2019: 9.0×FY 2020: 60.8×FY 2021: 32.5×FY 2022: 13.3×FY 2023: 6.1×FY 2024: 3.3×FY 2025: 5.3×
FY 2016 5y median 6.1× FY 2025
FCF Yield 2.4%
FY 2016: -5.7%FY 2017: -6.1%FY 2018: -5.5%FY 2019: -5.1%FY 2020: -1.2%FY 2021: -0.9%FY 2022: -0.2%FY 2023: 0.4%FY 2024: 2.0%FY 2025: 2.4%
FY 2016 5y median 0.4% FY 2025

Profitability

Gross Margin 46.0%
FY 2016: 39.3%FY 2017: 40.8%FY 2018: 40.2%FY 2019: 41.6%FY 2020: 45.1%FY 2021: 46.9%FY 2022: 44.0%FY 2023: 40.1%FY 2024: 41.0%FY 2025: 46.0%
FY 2016 5y median 44.0% FY 2025
Operating Margin 30.5%
FY 2016: 20.4%FY 2017: 21.5%FY 2018: 34.6%FY 2019: 27.9%FY 2020: 26.8%FY 2021: 31.0%FY 2022: 28.4%FY 2023: 26.1%FY 2024: 26.6%FY 2025: 30.5%
FY 2016 5y median 28.4% FY 2025
Net Margin 22.5%
FY 2016: 14.3%FY 2017: 15.6%FY 2018: 24.9%FY 2019: 25.4%FY 2020: 30.1%FY 2021: 32.9%FY 2022: 29.0%FY 2023: 20.0%FY 2024: 18.0%FY 2025: 22.5%
FY 2016 5y median 22.5% FY 2025
ROE 10.1%
FY 2016: 52.2%FY 2017: 6.3%FY 2018: 7.9%FY 2019: 7.9%FY 2020: 8.2%FY 2021: 10.5%FY 2022: 12.6%FY 2023: 8.4%FY 2024: 8.0%FY 2025: 10.1%
FY 2016 5y median 10.1% FY 2025
ROIC 9.0%
FY 2016: 11.4%FY 2017: 7.2%FY 2018: 9.3%FY 2019: 6.5%FY 2020: 5.1%FY 2021: 7.4%FY 2022: 8.8%FY 2023: 7.7%FY 2024: 8.0%FY 2025: 9.0%
FY 2016 5y median 8.0% FY 2025
ROA 7.5%
FY 2016: 7.1%FY 2017: 5.2%FY 2018: 6.7%FY 2019: 5.8%FY 2020: 5.8%FY 2021: 7.7%FY 2022: 8.9%FY 2023: 6.0%FY 2024: 5.9%FY 2025: 7.5%
FY 2016 5y median 7.5% FY 2025

Growth (YoY)

Revenue 13.7%
FY 2016: 77.6%FY 2017: 63.7%FY 2018: 56.6%FY 2019: 57.2%FY 2020: 40.9%FY 2021: 83.3%FY 2022: 48.4%FY 2023: 11.6%FY 2024: 9.6%FY 2025: 13.7%
FY 2016 FY 2025
Operating Income 30.2%
FY 2016: 223.9%FY 2017: 73.0%FY 2018: 151.4%FY 2019: 26.6%FY 2020: 35.3%FY 2021: 112.3%FY 2022: 36.2%FY 2023: 2.5%FY 2024: 11.8%FY 2025: 30.2%
FY 2016 FY 2025
EPS (diluted) 43.6%
FY 2016: 216.8%FY 2017: 76.6%FY 2018: 118.3%FY 2019: 56.3%FY 2020: 60.0%FY 2021: 92.5%FY 2022: 31.2%FY 2023: -23.8%FY 2024: 1.3%FY 2025: 43.6%
FY 2016 FY 2025
Free Cash Flow 117.4%
FY 2016: -52.7%FY 2017: 5.6%FY 2018: -226.4%FY 2019: -89.6%FY 2020: -104.5%FY 2021: 25.4%FY 2022: 89.4%FY 2023: 233.8%FY 2024: 194.5%FY 2025: 117.4%
FY 2016 FY 2025

Financial Health

Current Ratio 3.1×
FY 2016: 1.0×FY 2017: 3.8×FY 2018: 4.4×FY 2019: 3.4×FY 2020: 3.2×FY 2021: 2.4×FY 2022: 2.0×FY 2023: 2.8×FY 2024: 2.7×FY 2025: 3.1×
FY 2016 5y median 2.7× FY 2025
Quick Ratio 3.0×
FY 2016: 0.9×FY 2017: 3.6×FY 2018: 4.2×FY 2019: 3.2×FY 2020: 2.9×FY 2021: 2.2×FY 2022: 1.7×FY 2023: 2.5×FY 2024: 2.6×FY 2025: 3.0×
FY 2016 5y median 2.5× FY 2025
Debt / Equity 0.1×
FY 2016: 4.2×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.2×FY 2020: 0.2×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -0.7×
FY 2016: 3.0×FY 2017: -1.1×FY 2018: -4.6×FY 2019: -2.9×FY 2020: -1.6×FY 2021: -1.0×FY 2022: -0.3×FY 2023: -0.9×FY 2024: -0.5×FY 2025: -0.7×
FY 2016 5y median -0.7× FY 2025
Interest Coverage 46.5×
FY 2016: 8.3×FY 2017: 9.8×FY 2018: 0.0×FY 2019: 56.6×FY 2020: 35.2×FY 2021: 81.3×FY 2022: 67.4×FY 2023: 28.1×FY 2024: 31.6×FY 2025: 46.5×
FY 2016 5y median 46.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31